Pharsight

Naproxen Sodium patents expiration

NAPROXEN SODIUM's oppositions filed in EPO
NAPROXEN SODIUM IPR and PTAB Proceedings
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10028925 BIONPHARMA Liquid dosage forms of sodium naproxen
Mar, 2026

(1 year, 8 months from now)

US10022344 BIONPHARMA Liquid dosage forms of sodium naproxen
Mar, 2026

(1 year, 8 months from now)

US11090280 BIONPHARMA Liquid dosage forms of sodium naproxen
Mar, 2026

(1 year, 8 months from now)

US9693979 BIONPHARMA Liquid dosage forms of sodium naproxen
Mar, 2026

(1 year, 8 months from now)

US9693978 BIONPHARMA Solvent system for enhancing the solubility of pharmaceutical agents
Mar, 2026

(1 year, 8 months from now)

Naproxen Sodium is owned by Bionpharma.

Naproxen Sodium contains Naproxen Sodium.

Naproxen Sodium has a total of 5 drug patents out of which 0 drug patents have expired.

Naproxen Sodium was authorised for market use on 17 February, 2006.

Naproxen Sodium is available in capsule;oral dosage forms.

Naproxen Sodium can be used as temporary reduction of fever.

The generics of Naproxen Sodium are possible to be released after 03 March, 2026.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using NAPROXEN SODIUM ingredient

Market Authorisation Date: 17 February, 2006

Treatment: Temporary reduction of fever

Dosage: CAPSULE;ORAL

How can I launch a generic of NAPROXEN SODIUM before it's drug patent expiration?
More Information on Dosage

NAPROXEN SODIUM family patents

Family Patents